This provider's $7.8M in total Medicare payments ranks in the 99th percentile of Nuclear Medicine providers nationally.
Medicare payments to this provider grew 976% from 2015 to 2023.
60% of their billing comes from a single procedure code (78815 — Nuclear medicine study with CT imaging skull base to mid-thigh).
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 252% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2015 | $2.9K | $702.83 | 4.16x | $2.2K | $170.8K | 251 | 249 |
| 2016 | $1.9K | $469.32 | 4.00x | $1.4K | $600.9K | 1.0K | 894 |
| 2017 | $1.6K | $522.81 | 3.06x | $1.1K | $183.3K | 297 | 274 |
| 2018 | $2.2K | $693.37 | 3.22x | $1.5K | $158.8K | 220 | 220 |
| 2019 | $2.2K | $645.63 | 3.44x | $1.6K | $338.8K | 484 | 472 |
| 2020 | $2.2K | $779.97 | 2.83x | $1.4K | $949.9K | 1.2K | 1.1K |
| 2021 | $2.9K | $1.1K | 2.56x | $1.8K | $1.7M | 1.8K | 1.6K |
| 2022 | $2.3K | $777.59 | 2.92x | $1.5K | $1.9M | 2.1K | 1.9K |
| 2023 | $2.3K | $785.52 | 2.89x | $1.5K | $1.8M | 2.2K | 2.0K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 3.1K | $4.7M | $1.5K | 3.36x |
| A9584 | Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | 394 | $812.7K | $2.1K | 2.90x |
| 78816 | Nuclear medicine study with CT imaging whole body | 269 | $398.7K | $1.5K | 3.61x |
| 78608 | Nuclear medicine study brain with metabolic evaluation | 223 | $315.6K | $1.4K | 3.53x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 3.2K | $282.2K | $87.98 | 9.66x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 275 | $244.3K | $888.46 | 1.65x |
| A9597 | Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified | 44 | $167.0K | $3.8K | 1.98x |
| Q9983 | Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries | 75 | $166.0K | $2.2K | 2.26x |
| 78814 | Nuclear medicine study with CT imaging | 110 | $164.0K | $1.5K | 3.35x |
| A9588 | Fluciclovine f-18, diagnostic, 1 millicurie | 39 | $135.7K | $3.5K | 1.74x |
| 78830 | Spect nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, with concurrently acquired ct transmission scan, 1 day of imaging | 253 | $114.6K | $452.93 | 1.99x |
| 78999 | Diagnostic nuclear medicine procedures | 229 | $51.8K | $226.17 | 4.38x |
| A9587 | Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | 117 | $48.5K | $414.44 | 2.21x |
| 78459 | Single nuclear medicine study of heart muscle with metabolic evaluation | 26 | $34.4K | $1.3K | 3.78x |
| 78607 | Nuclear medicine study of brain | 98 | $32.1K | $327.79 | 2.29x |
| 78306 | Bone and/or joint imaging, whole body | 102 | $28.9K | $282.93 | 1.89x |
| J3240 | Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial | 22 | $27.1K | $1.2K | 2.03x |
| 78803 | Spect nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, 1 day of imaging | 77 | $26.6K | $345.84 | 2.17x |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 30 | $26.6K | $885.21 | 1.81x |
| 78315 | Bone and/or joint imaging, 3 phase study | 68 | $22.0K | $324.19 | 2.23x |
This provider submits charges 3.39 times higher than what Medicare actually pays.
A markup ratio of 3.39x means for every $100 Medicare pays, this provider initially charges $339. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data